PATENT CLAIM ANALYSIS

Application Number: 16036670
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["514", "050000"]

Abstract:
Compounds, compositions, and methods of treatment and prevention of HIV infection are disclosed. The compounds are pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidine JAK inhibitors. Combinations of these JAK inhibitors and additional antiretroviral compounds, such as NRTI, NNRTI, integrase inhibitors, entry inhibitors, protease inhibitors, and the like, are also disclosed. In one embodiment, the combinations include a combination of adenine, cytosine, thymidine, and guanine nucleoside antiviral agents, optionally in further combination with at least one additional antiviral agent that works via a different mechanism than a nucleoside analog. This combination has the potential to eliminate the presence of HIV in an infected patient.

Claim (Index 12):
The method of  claim 11 , further comprising administration of HAART along with the JAK inhibitor.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 95.0
- Lexical Diversity: 1.7027
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14360905', '14808860', '13293828', '14512262', '12784916']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7173704631164945
- 35 USC 102 Novelty (BERT): 0.6424481028593373
- Combined Prediction Score: 0.7098782270907789
- Mean Citation Score: 448.166796
- Max Citation Score: 695.8886
- Similarity Product: 537.3954479042053

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test